All states

Telehealth · CO

Colorado

Colorado residents can now access GLP-1 medications like semaglutide and tirzepatide through telehealth — from Denver and the Front Range to mountain towns and the Western Slope. Pallas Health connects you with a board-certified provider licensed in Colorado who can evaluate your eligibility in under 5 minutes and, if appropriate, prescribe medication that ships to any Colorado address in a few business days.

Licensed by
Colorado Medical Board
Telehealth
Async + video
Compounded semaglutide
Available
Compounded tirzepatide
Available
Medicaid
Limited coverage
Shipping
2–3 business days

How telehealth prescribing works in Colorado

Colorado permits licensed providers to use telehealth to establish a patient relationship and prescribe non-controlled medications like GLP-1s, including synchronous video and, in appropriate cases, asynchronous review when the standard of care is met.

Colorado requires any provider writing a prescription to a Colorado resident to hold an active Colorado medical license — out-of-state licensure is not sufficient. Under C.R.S. § 12-240-107 and Colorado Medical Board telehealth policy, licensed providers may use telemedicine to establish the provider-patient relationship and prescribe non-controlled medications, including via synchronous video and, in appropriate cases, asynchronous review when the standard of care is met. Colorado is also a full member of the Interstate Medical Licensure Compact (IMLC), which streamlines licensure for qualifying providers but does not waive the Colorado-license requirement to treat Colorado patients. Every Pallas clinician who treats Colorado patients is individually licensed by the Colorado Medical Board. GLP-1s are not controlled substances, so Colorado's separate Prescription Drug Monitoring Program and controlled-substance telemedicine requirements don't add friction here, but our providers still document a complete history, screen for contraindications like personal or family history of medullary thyroid carcinoma, and schedule follow-up visits to monitor response and titrate the dose.

Rule changes affecting Colorado

  1. 2026-07-27

    Correction — statute and rule citations updated on four state pages: Vermont now cites 18 V.S.A. § 9361(b) (previously a nonexistent § 3053a), Ohio cites Ohio Rev. Code § 4743.09 and OAC 4731-37-01 (previously the controlled-substances chapter 4731-11), Colorado cites C.R.S. § 12-240-107 (previously § 12-240-138, the professional-entities section), and Alabama cites Ala. Code §§ 34-24-701 through 34-24-707 (previously the repealed Admin. Code ch. 540-X-15). Regulatory substance is unchanged in all four.

    State statute and administrative-code databases; surfaced by our automated source check (PR #45).

From our state-by-state rules tracker — get an email when a rule changes.

Medicaid & insurance in Colorado

Limited coverage

Health First Colorado (Colorado Medicaid) covers GLP-1s for type 2 diabetes with prior authorization. Coverage for weight-management indications is limited. Compounded GLP-1s are not covered.

Pallas is a cash-pay telehealth service. Medicaid and private insurance do not apply to our prescriptions; pricing is flat and disclosed up front.

Simple cash-pay pricing in Colorado

No insurance, and the same price in every Colorado ZIP code. You see your full price during intake, before you pay anything.

Compounded plans · provider care included

  • Compounded semaglutide injection$139 first month, then $199 every 4 weeks, charged once a clinician prescribes, then until you cancel
  • Compounded tirzepatide injection$179 first month, then $299 every 4 weeks, charged once a clinician prescribes, then until you cancel
  • Compounded semaglutide daily tablet$777 every 12 weeks ($259/mo avg), charged once a clinician prescribes, then until you cancel

Your plan price covers your US-licensed provider, ongoing check-ins, dose adjustments, and unlimited care-team messaging — no separate membership fee. Medication ships free and discreet, only if prescribed; nothing is charged until a clinician prescribes. Cancel anytime. Pay-over-time options are available at checkout.

See the full Colorado cost guide

Brand-name · FDA-approved

FDA-approved Wegovy® (pen or pill), Zepbound® and Foundayo™ for chronic weight management, plus Ozempic® and Mounjaro® for type 2 diabetes, are available cash-pay: the daily Wegovy® pill and Foundayo™ are $299 for your first month, then $499 every 4 weeks; the weekly pens start at $1,069/mo. Your clinician helps determine which option is appropriate for you.

Pallas offers both FDA-approved and compounded medications. Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary. Private pay only (no insurance). Operated by Brentmoor, Inc.

Semaglutide vs tirzepatide in Colorado

Both are once-weekly injections available to Colorado patients through Pallas, as compounded preparations and as the FDA-approved brand-name products. They work differently: semaglutide activates the GLP-1 receptor, while tirzepatide activates both the GLP-1 and GIP receptors — two of the gut hormones that regulate appetite and fullness.

In SURMOUNT-5, the head-to-head clinical trial of the FDA-approved products, Zepbound® (tirzepatide 10 mg or 15 mg weekly) produced greater average weight loss than Wegovy® (semaglutide 1.7 mg or 2.4 mg weekly) — 20.2% versus 13.7% of body weight over 72 weeks — with broadly similar tolerability. That trial predates Wegovy®'s higher 7.2 mg weekly dose, which reached 18.7% average weight loss over 72 weeks in the separate STEP UP trial; separate trials do not provide a direct comparison. Clinical trial outcomes for the FDA-approved products have not been established for compounded preparations. Individual results vary.

Cost and track record differ too: compounded semaglutide renews at $199 every 4 weeks versus $299 for tirzepatide (full terms above), and semaglutide has the longer post-market record. Which medication fits your health history, goals, and budget is a decision you make with a clinician licensed in Colorado — our full semaglutide vs tirzepatide comparison covers the deeper differences.

Cities served in Colorado

Partner pharmacies ship to every ZIP code in Colorado, including:

  • Denver
  • Colorado Springs
  • Aurora
  • Fort Collins
  • Lakewood
  • Thornton
  • Arvada
  • Boulder

Colorado GLP-1 questions

Start Pallas's online intake — it takes under five minutes and covers your health history, goals, and current medications. Because Colorado allows asynchronous-first care, a Colorado-licensed clinician typically reviews your intake by secure message, without a scheduled video call, though they may request one if your history calls for it. If a GLP-1 is clinically appropriate, your clinician sends the prescription to a licensed pharmacy, which ships to any Colorado address within 2–3 business days.

Start the same online intake used for semaglutide — it takes under five minutes. A Colorado-licensed clinician reviews your history and, if tirzepatide is clinically appropriate, can prescribe compounded tirzepatide, prepared per-patient by a US-licensed pharmacy under FDCA §503A based on a documented clinical rationale. FDA-approved Zepbound® and Mounjaro® (tirzepatide) are also available cash-pay through the same intake — your clinician will discuss which option fits your history; the compounded and brand-name preparations are not interchangeable.

Yes — compounded semaglutide is available to eligible Colorado residents through licensed telehealth. It is prepared per-patient by US-licensed compounding pharmacies under FDCA §503A, and a Colorado-licensed clinician must prescribe it based on a documented, patient-specific clinical rationale. Pallas serves Colorado with free shipping. FDA-approved brand-name options like Wegovy® and Zepbound® are also available through the same intake.

Yes, within the limits of Colorado's nurse practitioner scope of practice. Colorado is a full-practice-authority state — a nurse practitioner whose prescriptive authority has become full after completing 750 documented hours of a structured prescribing mentorship may prescribe independently, with no ongoing physician agreement required, under C.R.S. §12-255-112 and 3 CCR 716-1.15. Physicians licensed in Colorado can also prescribe independently. Every Pallas prescription for a Colorado patient is written by a Colorado-licensed physician or, where applicable, a nurse practitioner practicing within these requirements.

Several licensed telehealth platforms serve Colorado residents seeking compounded semaglutide. Before choosing one, verify that its clinicians are licensed in Colorado, that it works with US-licensed §503A compounding pharmacies, and that the company is LegitScript certified — LegitScript's public database lets you check any platform's certification status. Pallas Health serves Colorado residents.

No — Colorado allows asynchronous-first care. A Colorado-licensed provider can review your intake by secure message and prescribe semaglutide without a scheduled video call, provided the standard of care is met. Your provider may request a video visit or additional information only if your history calls for it.

Most Colorado patients complete Pallas's online intake in about five minutes, and a Colorado-licensed clinician typically reviews it within one to two business days, since Colorado allows this review to happen asynchronously by secure message rather than a scheduled video call. Once your clinician prescribes, a US-licensed pharmacy fills and ships your medication, typically within 2–3 business days of the pharmacy filling the prescription. The most common delays are an incomplete intake or an issue verifying your ID or photos, so responding quickly to any follow-up message from your care team keeps things on track. There's no guaranteed delivery date, since timing depends on your individual history and pharmacy processing.

Yes — telehealth access through Pallas is the same across Colorado, whether you're in Denver, Colorado Springs, Aurora, Fort Collins, or a smaller community on the Western Slope or in a mountain town. A Colorado-licensed clinician reviews every intake the same way regardless of ZIP code, and licensed partner pharmacies ship both compounded medications and FDA-approved brands like Wegovy® and Zepbound® to any Colorado address. Distance from a major metro does not change your eligibility or your care.

Several telehealth providers prescribe tirzepatide to Colorado residents. Before choosing one, verify that its clinicians hold an active Colorado medical license, that it works with US-licensed §503A compounding pharmacies (or offers FDA-approved Zepbound®/Mounjaro® as the brand-name option), and that it carries LegitScript Healthcare Merchant Certification — checkable in LegitScript's public database. Pallas serves Colorado residents.

Health First Colorado covers GLP-1s for type 2 diabetes with prior authorization. Coverage for weight-management indications is limited. Compounded GLP-1s are not covered. Pallas is a cash-pay telehealth service, so Medicaid rules do not affect our pricing.

Pallas is a cash-pay telehealth service — there is no insurance to bill. Your Pallas Membership covers your clinician's review, ongoing check-ins, and care-team messaging; the medication is billed separately and ships free to your Colorado address, only when a clinician prescribes it. You see your full price during intake before you pay anything — no surprise renewal markups. The price is the same whether you are in Denver, Colorado Springs, or a mountain-town ZIP code.

In general, GLP-1 medications for weight management are considered for adults with a BMI of 30 or higher, or a BMI of 27 or higher together with a weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnea. Eligibility is always decided by a Colorado-licensed clinician after reviewing your full intake and medical history, never by an automated quiz — they will tell you directly if a GLP-1 is not appropriate for you.

Brand-name medications — Wegovy® and Ozempic® (semaglutide) and Zepbound® and Mounjaro® (tirzepatide) — are FDA-approved products from their manufacturers, offered cash-pay. Compounded semaglutide and tirzepatide are prepared on a per-patient basis by US-licensed compounding pharmacies, regulated under federal law (FDCA §503A) and by state boards of pharmacy, when a clinician documents a patient-specific clinical need — a legal, established path when a Colorado-licensed provider prescribes it and a licensed compounding pharmacy dispenses it; Pallas works only with U.S. state-licensed 503A and 503B compounding pharmacies. While these pharmacies are highly regulated, the compounded medications themselves are not FDA-approved, are not generic versions of brand-name drugs, and have not been evaluated by the FDA for safety, efficacy, or quality. Which option fits you is a clinical decision you make with your Colorado-licensed provider.

Yes, many patients transfer their care to Pallas. During intake you tell your clinician which medication and dose you take now and how you have tolerated it. Your Colorado-licensed provider reviews that history and, if appropriate, continues you at a comparable dose or adjusts your titration plan. Do not stop or change a prescription on your own — let your clinician guide any transition.

Most patients use a once-weekly injection with a very fine needle, but a compounded oral semaglutide tablet is available for people who would rather not inject. Both are prescribed only after a clinician confirms they are appropriate for you, and your provider can help you weigh which form fits your routine and goals.

The most common side effects are gastrointestinal — nausea, constipation, diarrhea, or reflux — and they are usually mildest when the dose is raised slowly, which is why clinicians titrate up gradually. GLP-1s are not right for everyone; they are avoided in people with a personal or family history of medullary thyroid carcinoma or MEN2, and during pregnancy. Your Pallas clinician screens for these before prescribing and stays available to help you manage any side effects.

You complete a detailed online intake in under five minutes, sharing your health history, goals, and current medications. A clinician licensed by the Colorado Medical Board reviews it asynchronously in most cases — no live video required — and may follow up by secure message or request labs if your history calls for it. If a GLP-1 is appropriate, your prescription goes to a licensed pharmacy that ships to any Colorado address, usually within a few business days.

Yes — your plan renews on a regular cadence so your medication arrives before you run out, and your clinician schedules check-ins to monitor your response, adjust your dose, and manage side effects. Pallas care is ongoing, not a one-time script. You can message your care team from the Pallas app or your patient portal, and change your plan or cancel anytime from the portal — no phone calls or retention hoops.

Compounded semaglutide injection through Pallas is $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. That one plan price includes your US-licensed provider, ongoing check-ins, dose adjustments, and unlimited care-team messaging — no separate membership fee. Medication ships free to any Colorado address, only if a clinician prescribes it, and nothing is charged until then.

Compounded tirzepatide injection through Pallas is $179 first month, then $299 every 4 weeks, charged once a clinician prescribes. Cancel anytime. That one plan price includes your US-licensed provider, ongoing check-ins, dose adjustments, and unlimited care-team messaging — no separate membership fee. Medication ships free to any Colorado address, only if a clinician prescribes it, and nothing is charged until then.

Yes. FDA-approved Wegovy® (pen or pill), Zepbound® and Foundayo™ for chronic weight management — plus Ozempic® and Mounjaro® for type 2 diabetes — are available to Colorado patients cash-pay: the daily Wegovy® pill and Foundayo™ are $299 for your first month, then $499 every 4 weeks, and the weekly pens start at $1,069/mo; insurance is not billed. Whether a brand-name or compounded medication is appropriate for you is determined by a clinician licensed in Colorado during intake.

Coverage of GLP-1 medications for weight loss through Health First Colorado is limited. Health First Colorado (Colorado Medicaid) covers GLP-1s for type 2 diabetes with prior authorization. Coverage for weight-management indications is limited. Compounded GLP-1s are not covered. Pallas is a cash-pay telehealth service — we do not bill Health First Colorado or private insurance. Pricing is flat and disclosed up front; the cost questions on this page carry current plan terms.

You have two cash-pay paths in Colorado, and neither requires insurance. One: stay on FDA-approved Wegovy® or Zepbound® at flat cash-pay pricing from $1,069/mo. Two: if a clinician licensed in Colorado determines it is clinically appropriate for you, a compounded semaglutide plan ($139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime.) or compounded tirzepatide plan ($179 first month, then $299 every 4 weeks, charged once a clinician prescribes. Cancel anytime.), prepared per-patient by a US-licensed pharmacy under FDCA §503A. There is no gap in care: start the online intake, tell your clinician what you take now and your current dose, and they factor that history into your treatment plan and starting dose. Our guide to switching GLP-1 telehealth providers on the Pallas blog covers records, timing, and what to expect.

That is a decision you make with your clinician. Semaglutide activates the GLP-1 receptor; tirzepatide activates both the GLP-1 and GIP receptors. In the SURMOUNT-5 head-to-head trial of the FDA-approved products, Zepbound® (tirzepatide 10 mg or 15 mg weekly) produced greater average weight loss than Wegovy® (semaglutide 1.7 mg or 2.4 mg weekly) — 20.2% versus 13.7% of body weight over 72 weeks. Wegovy®'s maximum dose is now 7.2 mg weekly, which was not studied in SURMOUNT-5; in the separate STEP UP trial it reached 18.7% average weight loss over 72 weeks. Clinical trial outcomes for the FDA-approved products have not been established for compounded preparations. Individual results vary. Semaglutide plans cost less and semaglutide has the longer post-market record; a clinician licensed in Colorado weighs your history, goals, and budget to recommend a starting point.

It depends on what you are comparing. Pallas is a cash-pay telehealth service that serves every ZIP code in Colorado with one all-in plan price for compounded semaglutide: $139 first month, then $199 every 4 weeks, charged once a clinician prescribes. Cancel anytime. There is no separate membership fee, and nothing is charged until a clinician prescribes. No video visit is required in Colorado. Before paying any service, check whether the quoted price includes the medication or is a membership billed on top of it, whether the company is LegitScript-certified, and whether you are charged before a clinician has prescribed.

Start your Colorado intake

Under 5 minutes. Reviewed by a clinician licensed in Colorado.

Start intake